CD47 and cancer: The physiological selection pressures that have maintained this microsynteny remain unknown, but recognition of this coregulation is important for interpreting many recent publications that have identified transcriptional regulators relevant to cancer that control the expression of CD47 and correlate with cancer survival or responses to therapy [17,18,19,20,21,22,23].